English
Español
CONTACT US
HOME

ONCOMATRYX

pioneering stromal medicine

Month: December 2015

Capital Increase

Published by La Vanguardia 2015-12-15. Oncomatryx expands capital to complete the preclinical phase of drugs against tumor stroma The Basque company Oncomatryx has completed a round of capital increase of

Oncomatryx2015-12-152019-07-09 PRESS Releases No Comments Read more

War on cancer stroma: a novel pathway to treat pancreatic cancer

War on cancer stroma: a novel pathway to treat pancreatic cancer By Laureano Simon, CEO at Oncomatryx Pancreatic cancer is the fourth most fatal cancer in men and women. Most patients

Oncomatryx2015-12-042016-11-15 TEAM POSTS No Comments Read more

Meta

UE Next Generation

This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.

PRECISION DRUGS

PRECISION DRUGS
ANTIBODY DRUG CONJUGATES
PIPELINE

DIAGNOSTICS

COL11A1 BIOMARKER
INVASIVE TUMOR DIAGNOSTICS -invaScan-
BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

English
Español
TERMS OF USE
PRIVACY POLICY
SITE MAP

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.